BIT 0.00% 3.0¢ biotron limited

I think you got her there mate....this would be a major...

  1. 2,021 Posts.
    lightbulb Created with Sketch. 307

    I think you got her there mate....this would be a major scandal.  Here's all some proof for disqualification for listing.  Everyone sell!


    Select item 268587711.

    The antiviral compound BIT225 inhibits HIV-1 replication in myeloid dendritic cells.

    Khoury G, Ewart G, Luscombe C, Miller M, Wilkinson J.

    AIDS Res Ther. 2016 Feb 8;13:7. doi: 10.1186/s12981-016-0093-z. eCollection 2016.

    Select item 201564862.

    A novel Hepatitis C virus p7 ion channel inhibitor, BIT225, inhibits bovine viral diarrhea virus in vitro and shows synergism with recombinant interferon-alpha-2b and nucleoside analogues.

    Luscombe CA, Huang Z, Murray MG, Miller M, Wilkinson J, Ewart GD.

    Antiviral Res. 2010 May;86(2):144-53. doi: 10.1016/j.antiviral.2010.02.312. Epub 2010 Feb 13.

    PMID:
    20156486
    Select item 266201013.

    A Phase 1b/2a study of the safety, pharmacokinetics and antiviral activity of BIT225 in patients with HIV-1 infection.

    Wilkinson J, Ewart G, Luscombe C, McBride K, Ratanasuwan W, Miller M, Murphy RL.

    J Antimicrob Chemother. 2016 Mar;71(3):731-8. doi: 10.1093/jac/dkv389. Epub 2015 Nov 29.

    PMID:
    26620101
    Select item 199959244.

    Antiviral efficacy of the novel compound BIT225 against HIV-1 release from human macrophages.

    Khoury G, Ewart G, Luscombe C, Miller M, Wilkinson J.

    Antimicrob Agents Chemother. 2010 Feb;54(2):835-45. doi: 10.1128/AAC.01308-09. Epub 2009 Dec 7.

 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.0¢
Change
0.000(0.00%)
Mkt cap ! $27.06M
Open High Low Value Volume
3.0¢ 3.0¢ 3.0¢ $5.252K 175.9K

Buyers (Bids)

No. Vol. Price($)
2 707862 2.9¢
 

Sellers (Offers)

Price($) Vol. No.
3.0¢ 79328 3
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.